Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Atherosclerosis Reports
Metadata
Title
Low-density lipoprotein particle number and risk for cardiovascular disease
Authors
William C. Cromwell, MD
James D. Otvos, PhD
Publication date
01-09-2004
Publisher
Current Medicine Group
Published in
Current Atherosclerosis Reports / Issue 5/2004
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-004-0050-5

Other articles of this Issue 5/2004

Current Atherosclerosis Reports 5/2004 Go to the issue

Announcement

Web alert

OriginalPaper

High-density lipoprotein subfractions and risk of coronary artery disease

OriginalPaper

Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk

OriginalPaper

ASCOT-LLA and the primary prevention of coronary artery disease in hypertensive patients

OriginalPaper

Hepatic lipase: Friend or foe and under what circumstances?

OriginalPaper

ALLHAT-LLT: Questions, questions, and more questions (and some answers)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits